DE60327328D1 - 6,7-DIHYDRO-5H-PYRAZOLOi1,2-A PYRAZOL-1-ONE ZUR KONTROLLE VON ENTZÜNDUNGSFÖRDERNDEN CYTOKINEN - Google Patents

6,7-DIHYDRO-5H-PYRAZOLOi1,2-A PYRAZOL-1-ONE ZUR KONTROLLE VON ENTZÜNDUNGSFÖRDERNDEN CYTOKINEN

Info

Publication number
DE60327328D1
DE60327328D1 DE60327328T DE60327328T DE60327328D1 DE 60327328 D1 DE60327328 D1 DE 60327328D1 DE 60327328 T DE60327328 T DE 60327328T DE 60327328 T DE60327328 T DE 60327328T DE 60327328 D1 DE60327328 D1 DE 60327328D1
Authority
DE
Germany
Prior art keywords
pyrazol
dihydro
interleukin
inflammatory cytokines
pyrazoloi1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60327328T
Other languages
English (en)
Inventor
Michael Phillip Clark
Matthew John Laufersweiler
Adam Golebiowski
Mark P Sabat
Todd Andrew Brugel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of DE60327328D1 publication Critical patent/DE60327328D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60327328T 2002-09-18 2003-03-18 6,7-DIHYDRO-5H-PYRAZOLOi1,2-A PYRAZOL-1-ONE ZUR KONTROLLE VON ENTZÜNDUNGSFÖRDERNDEN CYTOKINEN Expired - Fee Related DE60327328D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/246,214 US6730668B2 (en) 2001-09-20 2002-09-18 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
PCT/US2003/008477 WO2004026878A1 (en) 2002-09-18 2003-03-18 6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY CYTOKINES

Publications (1)

Publication Number Publication Date
DE60327328D1 true DE60327328D1 (de) 2009-06-04

Family

ID=32028948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60327328T Expired - Fee Related DE60327328D1 (de) 2002-09-18 2003-03-18 6,7-DIHYDRO-5H-PYRAZOLOi1,2-A PYRAZOL-1-ONE ZUR KONTROLLE VON ENTZÜNDUNGSFÖRDERNDEN CYTOKINEN

Country Status (20)

Country Link
US (3) US6730668B2 (de)
EP (1) EP1539761B1 (de)
JP (1) JP2006502189A (de)
KR (3) KR20050057444A (de)
CN (1) CN1315834C (de)
AT (1) ATE429434T1 (de)
AU (1) AU2003218280B8 (de)
BR (1) BR0314292A (de)
CA (1) CA2496500A1 (de)
DE (1) DE60327328D1 (de)
ES (1) ES2322046T3 (de)
IL (1) IL166822A0 (de)
MA (1) MA27434A1 (de)
MX (1) MXPA05002984A (de)
NO (1) NO20051686L (de)
NZ (1) NZ538197A (de)
PL (1) PL376086A1 (de)
RU (1) RU2289584C2 (de)
WO (1) WO2004026878A1 (de)
ZA (1) ZA200501590B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) * 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6566357B1 (en) * 2001-09-20 2003-05-20 The Procter & Gamble Co. Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7326714B2 (en) * 2001-09-20 2008-02-05 The Procter & Gamble Company 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
NZ596123A (en) * 2009-05-19 2014-08-29 Dow Agrosciences Llc Compounds and methods for controlling fungi
US10512628B2 (en) 2016-04-24 2019-12-24 Solano S.P. Ltd. Dinotefuran liquid flea and tick treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US6472416B1 (en) * 1999-08-27 2002-10-29 Abbott Laboratories Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
US6566357B1 (en) * 2001-09-20 2003-05-20 The Procter & Gamble Co. Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
MA27434A1 (fr) 2005-07-01
ES2322046T3 (es) 2009-06-16
KR20070051374A (ko) 2007-05-17
KR20050057444A (ko) 2005-06-16
RU2005111220A (ru) 2006-02-27
US20030134867A1 (en) 2003-07-17
AU2003218280B2 (en) 2008-05-15
PL376086A1 (en) 2005-12-12
EP1539761B1 (de) 2009-04-22
KR20070087684A (ko) 2007-08-28
CN1315834C (zh) 2007-05-16
CA2496500A1 (en) 2004-04-01
JP2006502189A (ja) 2006-01-19
MXPA05002984A (es) 2005-06-22
CN1681819A (zh) 2005-10-12
IL166822A0 (en) 2006-01-15
NZ538197A (en) 2007-01-26
NO20051686L (no) 2005-04-05
AU2003218280A1 (en) 2004-04-08
ZA200501590B (en) 2006-02-22
US7368455B2 (en) 2008-05-06
US6730668B2 (en) 2004-05-04
AU2003218280B8 (en) 2008-06-26
US6960593B2 (en) 2005-11-01
US20040058944A1 (en) 2004-03-25
EP1539761A1 (de) 2005-06-15
RU2289584C2 (ru) 2006-12-20
ATE429434T1 (de) 2009-05-15
KR100842191B1 (ko) 2008-06-30
BR0314292A (pt) 2005-12-13
WO2004026878A1 (en) 2004-04-01
US20050282844A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ZA200501590B (en) 6,7-Dihydro-5H-pyrazoloÄ1,2-aÜpyrazol-1-ones whichcontrol inflammatory cytokines.
NO20054959D0 (no) Fremgangsmater for behandling av interleukin-6 relaterte sykdommer
ES2193256T3 (es) Aril pirroles 2-sustituidos, composiciones que contienen tales compuestos y procedimientos de uso.
MXPA05010958A (es) Derivados indazol como inhibidores jnk.
EA200601571A1 (ru) 3-[4-гетероциклил-1,2,3-триазол-1-ил]-n-арилбензамиды в качестве ингибиторов продуцирования цитокинов, предназначенные для лечения хронических воспалительных заболеваний
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
FI963101A0 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
WO2005014533A3 (en) Aryl and heteroaryl compounds, compositions, and methods of use
MXPA03008955A (es) Agente terapeutico para enfermedades de tipo artritides cronicas o enfermedades relacionadas con la ninez.
WO2008064321A3 (en) Methods of treating chronic inflammatory diseases using a gm-csf antagonist
WO2001087328A3 (en) Interleukin-1 inhibitors in the treatment of diseases
DK1525200T3 (da) 2-(3-aminoaryl)amino-4-aryl-thiazoler til sygdomsbehandling
DE602004024374D1 (de) Zusammensetzungen zur verwendung als protein-kinase-inhibitoren
WO2004089286A3 (en) Novel compounds and compositions as protein kinase inhibitors
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
DE60327745D1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
ATE540948T1 (de) Pyrrolopyridine als proteinkinasehemmer
RU95113454A (ru) Катехольные диэфиры как селективные ингибиторы фдэiv, фармацевтическая композиция, способы лечения
IL163090A (en) Nicotinamide derivates, pharmaceutical compositions comprising them and their use for manufacture of medicaments useful as p38 inhibitors
SE9800836D0 (sv) New Compounds
EA200801711A1 (ru) Пролекарства возбуждающих аминокислот
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE476438T1 (de) Makrolide mit entzündungshemmender wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee